Thompson TC - Search Results

1

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.

Nasu Y, Bangma CH, Hull GW, Yang G, Wang J, Shimura S, McCurdy MA, Ebara S, Lee HM, Timme TL, Thompson TC. Nasu Y, et al. Among authors: thompson tc. Prostate Cancer Prostatic Dis. 2001;4(1):44-55. doi: 10.1038/sj.pcan.4500494. Prostate Cancer Prostatic Dis. 2001. PMID: 12497062

2

Transforming growth factor beta 1 as a biomarker for prostate cancer.

Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. J Cell Biochem Suppl. 1992;16H:54-61. doi: 10.1002/jcb.240501212. J Cell Biochem Suppl. 1992. PMID: 1289674 Review.

3

Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.

Thompson TC, Egawa S, Kadmon D, Miller GJ, Timme TL, Scardino PT, Park SH. Thompson TC, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):79-85. doi: 10.1016/0960-0760(92)90190-t. J Steroid Biochem Mol Biol. 1992. PMID: 1525069

4

Experimental oncogene induced prostate cancer.

Thompson TC, Kadmon D, Timme TL, Merz VW, Egawa S, Krebs T, Scardino PT, Park SH. Thompson TC, et al. Cancer Surv. 1991;11:55-71. Cancer Surv. 1991. PMID: 1726789

5

Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.

Merz VW, Miller GJ, Krebs T, Timme TL, Kadmon D, Park SH, Egawa S, Scardino PT, Thompson TC. Merz VW, et al. Among authors: thompson tc. Mol Endocrinol. 1991 Apr;5(4):503-13. doi: 10.1210/mend-5-4-503. Mol Endocrinol. 1991. PMID: 1922083

6

The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate.

Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G, Thompson TC. Aihara M, et al. Among authors: thompson tc. Cancer. 1995 Jan 15;75(2):522-9. doi: 10.1002/1097-0142(19950115)75:2<522::aid-cncr2820750215>3.0.co;2-w. Cancer. 1995. PMID: 7529128

7

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G. Thompson TC, et al. Oncogene. 1995 Mar 2;10(5):869-79. Oncogene. 1995. PMID: 7534899

8

Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.

Timme TL, Truong LD, Slawin KM, Kadmon D, Park SH, Thompson TC. Timme TL, et al. Among authors: thompson tc. Microsc Res Tech. 1995 Mar 1;30(4):333-41. doi: 10.1002/jemt.1070300408. Microsc Res Tech. 1995. PMID: 7541677 Review.

9

Rapid allelotype analysis of p53 knockout mice.

Timme TL, Thompson TC. Timme TL, et al. Among authors: thompson tc. Biotechniques. 1994 Sep;17(3):460, 462-3. Biotechniques. 1994. PMID: 7818898 No abstract available.

10

DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.

Greene DR, Taylor SR, Aihara M, Yoshida K, Egawa S, Park SH, Timme TL, Yang G, Scardino PT, Thompson TC. Greene DR, et al. Among authors: thompson tc. Int J Cancer. 1995 Jan 27;60(3):395-9. doi: 10.1002/ijc.2910600321. Int J Cancer. 1995. PMID: 7829250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters